Combined electroacupuncture and auricular acupuncture for primary insomnia: a randomised controlled trial of dose-response effect. 30674705 2019 01 24 1024-2708 25 Suppl 2 2019 Feb Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J Combined electroacupuncture and auricular acupuncture for primary insomnia: a randomised controlled trial of dose-response effect. 28-33 Chung K F KF Department of Psychiatry, The University of Hong Kong. Yeung W F WF School of Chinese Medicine

Effect of Traditional East Asian Medicinal herbal tea (HT002) on insomnia: a randomized controlled pilot study. Complementary and alternative medicine treatment for insomnia has been sought due to the possible adverse effects of conventional pharmacotherapies. We performed a preliminary evaluation of the feasibility of using, and of the effect of a herbal tea (HT002), based on Traditional East Asian Medicine, in mild-to-moderate insomnia.Patients (n = 40) with mild-to-moderate insomnia were (...) randomized to the HT002 (n = 20) or waitlist (n = 20) groups. The HT002 group consumed HT002 twice daily for 4 weeks. Outcomes were assessed using the Insomnia Severity Scale (ISI), Pittsburgh Sleep Quality Index (PSQI), and 12-item Short Form Health Survey (SF-12) at baseline and after 4 and 8 weeks.The ISI score differences from baseline at weeks 4 and 8 were significantly greater in the HT002 than that in the waitlist group (week 4: -4.0 ± 0.8 vs. -0.4 ± 0.8, p < 0.05; week 8: -4.8 ± 0.7 vs. -0.9

Effective? Engaging? Secure? Applying the ORCHA-24 framework to evaluate apps for chronic insomnia disorder Effective? Engaging? Secure? Applying the ORCHA-24 framework to evaluate apps for chronic insomnia disorder | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Effective? Engaging? Secure? Applying the ORCHA-24 framework to evaluate apps for chronic insomnia disorder Article Text Original article Effective? Engaging? Secure? Applying

Eszopiclone for insomnia. Insomnia is a major public health issue affecting between 6% to 10% of the adult population in Western countries. Eszopiclone is a hypnotic drug belonging to a newer group of hypnotic agents, known as new generation hypnotics, which was marketed as being just as effective as benzodiazepines for this condition, while being safer and having a lower risk for abuse and dependence. It is the aim of the review to integrate evidence from randomised controlled trials (...) and to draw conclusions on eszopiclone's efficacy and safety profile, while taking methodological features and bias risks into consideration.To assess the efficacy and safety of eszopiclone for the treatment of insomnia compared to placebo or active control.We searched the Cochrane Central Register of Controlled trials (CENTRAL), MEDLINE, Embase, PsycINFO, PSYNDEX and registry databases (WHO trials portal, ClinicalTrials.gov) with results incorporated from searches to 10 February 2016. To identify trials

Melatonin (Slenyto) - insomnia (difficulty sleeping) in children and adolescents (2 to 18 years old) Slenyto | European Medicines Agency Search Search Menu Slenyto melatonin Table of contents Authorised This medicine is authorised for use in the European Union. Overview Slenyto is a medicine for treating insomnia (difficulty sleeping) in children and adolescents (2 to 18 years old) who have: autism spectrum disorder (ASD), a range of conditions that affects the patient’s social interactions (...) areas of the brain and helping to bring about sleep. Its levels in the blood normally increase after the onset of darkness and peak in the middle of the night. Patients with developmental conditions may produce less melatonin, leading to the development of insomnia. Slenyto increases levels of melatonin in the blood, helping them to sleep. Because Slenyto releases melatonin slowly over a few hours, it mimics the natural production of melatonin in the body. What benefits of Slenyto have been shown

Insomnia Top results for insomnia - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 (...) or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for insomnia The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence

Impact of group treatment for insomnia on daytime symptomatology: Analyses from a randomized controlled trial in primary care People typically seek primary health care for daytime symptoms and impairments they experience in association with their insomnia. However, few studies address the question of whether insomnia treatment can improve such symptomatology.To investigate whether a nurse-led group treatment program, based on the techniques of cognitive behavioral therapy for insomnia (CBT-I (...) ), improved daytime symptomatology in primary care patients with insomnia.Fatigue (Fatigue Severity Scale [FSS]; main outcome), mood (General Health Questionnaire and Montgomery-Asberg Depression Rating Scale), health-related quality of life (Short-Form Health Survey), general daytime functioning, specific daytime symptoms (individual items from the Insomnia Severity Index and Uppsala Sleep Inventory), and dysfunctional beliefs (Dysfunctional Beliefs and Attitudes about Sleep).A randomized controlled

Antidepressants for insomnia in adults. Insomnia disorder is a subjective condition of unsatisfactory sleep (e.g. sleep onset, maintenance, early waking, impairment of daytime functioning). Insomnia disorder impairs quality of life and is associated with an increased risk of physical and mental health problems including anxiety, depression, drug and alcohol abuse, and increased health service use. hypnotic medications (e.g. benzodiazepines and 'Z' drugs) are licensed for sleep promotion (...) , but can induce tolerance and dependence, although many people remain on long-term treatment. Antidepressant use for insomnia is widespread, but none is licensed for insomnia and the evidence for their efficacy is unclear. This use of unlicensed medications may be driven by concern over longer-term use of hypnotics and the limited availability of psychological treatments.To assess the effectiveness, safety and tolerability of antidepressants for insomnia in adults.This review incorporated the results

Benefits and Harms of Cranial Electrical Stimulation for Chronic Painful Conditions, Depression, Anxiety, and Insomnia: A Systematic Review. Cranial electrical stimulation (CES) is increasingly popular as a treatment, yet its clinical benefit is unclear.To review evidence about the benefits and harms of CES for adult patients with chronic painful conditions, depression, anxiety, and insomnia.Several databases from inception to 10 October 2017 without language restrictions and references from (...) with insomnia (n = 2), insomnia and anxiety (n = 1), or depression (n = 3) had inconclusive or conflicting results. Low-strength evidence suggested that CES does not cause serious side effects.Most trials had small sample sizes and short durations; all had high risk of bias due to inadequate blinding.Evidence is insufficient that CES has clinically important effects on fibromyalgia, headache, neuromusculoskeletal pain, degenerative joint pain, depression, or insomnia; low-strength evidence suggests modest

Psychological interventions: Web-based cognitive behaviour therapy for insomnia shows long-term efficacy in improving chronic insomnia Web-based cognitive behaviour therapy for insomnia shows long-term efficacy in improving chronic insomnia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using (...) your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Web-based cognitive behaviour therapy for insomnia shows long-term efficacy in improving chronic insomnia Article Text Commentary Psychological

Insomnia Insomnia - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Insomnia Last reviewed: February 2019 Last updated: April 2018 Summary One of the most common complaints reported in primary care. Unmanaged insomnia can cost over US $100 billion each year due to accidents and poor work productivity. Associated with anxiety, depression, and physical complaints. Diagnosis is made primarily by patient interview. Sleep (...) diaries, actigraphy, and polysomnography may assist in confirming diagnosis. Identification of the correct aetiology is essential, as interventions differ and may be harmful in some cases if the diagnosis is incorrect. Education regarding sleep hygiene techniques is useful to prevent chronic insomnia. The significant morbidity of insomnia indicates that it is a condition that warrants treatment. Definition As per the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), American

Treatments for Insomnia: A Review of Patient and Experiences and Perspectives Treatments for Insomnia: A Review of Patients’ and Caregivers’ Experiences and Perspectives | CADTH.ca Find the information you need Treatments for Insomnia: A Review of Patients’ and Caregivers’ Experiences and Perspectives Treatments for Insomnia: A Review of Patients’ and Caregivers’ Experiences and Perspectives Published on: September 27, 2017 Project Number: RD0039-000 Product Line: Research Type: Drug Report (...) Type: Peer-reviewed summary with critical appraisal Result type: Report Question What are patient, caregiver, or family member experiences with and perspectives of treatment and management of insomnia? Key Message Only patient perceptions were available for review, there were no relevant data on caregiver or family member experiences. Patients’ perceptions of and engagements with pharmacotherapy tend to vary in relation to nightly levels of fatigue, daytime responsibilities and social normalization

Trajectories of change and long-term outcomes in a randomised controlled trial of internet-based insomnia treatment to prevent depression Insomnia treatment using an internet-based cognitive-behavioural therapy for insomnia (CBT-I) program reduces depression symptoms, anxiety symptoms and suicidal ideation. However, the speed, longevity and consistency of these effects are unknown.To test the following: whether the efficacy of online CBT-I was sustained over 18 months; how rapidly the effects (...) of CBT-I emerged; evidence for distinct trajectories of change in depressive symptoms; and predictors of these trajectories.A randomised controlled trial compared the 6-week Sleep Healthy Using the Internet (SHUTi) CBT-I program to an attention control program. Adults (N=1149) with clinical insomnia and subclinical depression symptoms were recruited online from the Australian community.Depression, anxiety and insomnia decreased significantly by week 4 of the intervention period and remained

Management of Insomnia Disorder in Adults: Current State of the Evidence Management of Insomnia Disorder in Adults: Current State of the Evidence Focus of This Summary This is a summary of a systematic review that evaluated current evidence regarding the effectiveness, comparative effectiveness, and adverse effects of management strategies for insomnia disorder in adults. The systematic review synthesized evidence from 169 randomized controlled trials and 12 observational studies published (...) through January 2015. The full report, listing all studies, is available at www.effectivehealthcare.ahrq.gov/insomnia/. This summary is provided to assist in informed clinical decisionmaking. However, reviews of evidence should not be construed to represent clinical recommendations or guidelines. Background Insomnia involves dissatisfaction with sleep quantity or quality and is associated with difficulty initiating sleep, maintaining sleep, returning to sleep after early morning waking

Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series Chronic insomnia is common in patients with Parkinson's disease. There are limited data to guide its treatment in this patient population, especially in regards to non-pharmacologic interventions, some of which are highly effective in the non-Parkinson's disease population. The aim of this study is to describe a series of Parkinson's disease patients who underwent cognitive behavioral therapy for insomnia (CBTi (...) of CBTi (range 5-12). Significant increases in sleep efficiency (p = 0.02) and decreases in number of awakenings per night (p = 0.02) were found. Our data provide preliminary evidence that cognitive behavioral therapy is an effective treatment for insomnia in Parkinson's disease, and is well tolerated and well received by patients. Given the limited data supporting use of medications to treat chronic insomnia in Parkinson's disease, combined with their risks, randomized trials to demonstrate

Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority Trial Purpose Cognitive behavioral therapy for insomnia (CBT-I) and Tai Chi Chih (TCC), a movement meditation, improve insomnia symptoms. Here, we evaluated whether TCC is noninferior to CBT-I for the treatment of insomnia in survivors of breast cancer. Patients and Methods This was a randomized, partially blinded, noninferiority (...) trial that involved survivors of breast cancer with insomnia who were recruited from the Los Angeles community from April 2008 to July 2012. After a 2-month phase-in period with repeated baseline assessment, participants were randomly assigned to 3 months of CBT-I or TCC and evaluated at months 2, 3 (post-treatment), 6, and 15 (follow-up). Primary outcome was insomnia treatment response-that is, marked clinical improvement of symptoms by the Pittsburgh Sleep Quality Index-at 15 months. Secondary

Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical (...) Effectiveness and Guidelines Published on: June 26, 2017 Project Number: RB1113-000 Product Line: Research Type: Drug Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of medical cannabis or cannabinoids for the treatment of insomnia disorder in adults? What are the evidence-based guidelines regarding the use of medical cannabis or cannabinoids for the treatment of insomnia disorder in adults? Key Message One randomized controlled trial and one non-randomized

Current Practice Analysis: Interventions for Insomnia Disorder Current Practice Analysis: Interventions for Insomnia Disorder (Optimal Use Project, June 2017) | CADTH.ca CADTH Document Viewer Current Practice Analysis: Interventions for Insomnia Disorder (Optimal Use Project, June 2017) Table of Contents Search this document Current Practice Analysis: Interventions for Insomnia Disorder (Optimal Use Project, June 2017) June 2017 Introduction CADTH studied the use of interventions to treat (...) insomnia disorder (acute and chronic) in Canadian primary care practice. The study investigated current practices and trends in drug and non-drug therapies for patients with insomnia disorder from the perspective of family physicians, nurse practitioners, and pharmacists. The findings are based on a targeted literature review as well as on the results of qualitative research from surveys of primary care practitioners. This report presents a summary of findings. Issue Insomnia disorder is a common

Current Practice Analysis: Interventions for Insomnia Disorder Current Practice Analysis: Interventions for Insomnia Disorder (Optimal Use Project, June 2017) | CADTH.ca CADTH Document Viewer Current Practice Analysis: Interventions for Insomnia Disorder (Optimal Use Project, June 2017) Table of Contents Search this document Current Practice Analysis: Interventions for Insomnia Disorder (Optimal Use Project, June 2017) June 2017 Introduction CADTH studied the use of interventions to treat (...) insomnia disorder (acute and chronic) in Canadian primary care practice. The study investigated current practices and trends in drug and non-drug therapies for patients with insomnia disorder from the perspective of family physicians, nurse practitioners, and pharmacists. The findings are based on a targeted literature review as well as on the results of qualitative research from surveys of primary care practitioners. This report presents a summary of findings. Issue Insomnia disorder is a common

Insomnia and somnolence in idiopathic RBD: a prospective cohort study Although some sleep disorders are markers of prodromal Parkinson's disease and dementia with Lewy bodies, it is unclear whether insomnia and somnolence can predict disease. We assessed a large cohort of patients with idiopathic rapid eye movement sleep behavior disorder and age/sex matched controls, comparing the Epworth sleepiness scale, the Insomnia Severity Index, the Pittsburgh Sleep Quality Index, and polysomnographic (...) remaining disease-free (6.7+/-4.4 vs. 7.1+/-4.7, p = 0.70). Pittsburgh Index scores were higher in patients than controls (7.2+/-3.8 vs. 4.9+/-3.4, p = 0.004), mainly driven by the sleep disturbance/medication components (reflecting rapid eye movement sleep behavior disorder symptoms/treatment). Baseline Pittsburgh scores did not predict conversion to neurodegeneration, although sleep duration increased over time in those converting to neurodegenerative disease (+0.88+/-1.32 h, p = 0.014). Insomnia